Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Thyroid hormone action controls multiple components of cell junctions at the ventricular zone in the newborn rat brain. | Front Endocrinol (Lausanne) | 2023 | 36843608 | PubTator, text mining | PubMed |
| Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy. | Pharmaceutics | 2023 | 36839734 | PubTator, text mining | PubMed |
| The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in Pancreatic Adenocarcinoma. | Int J Mol Sci | 2023 | 36834898 | PubTator, text mining | PubMed |
| Microsatellite Instability and Aberrant Pre-mRNA Splicing: How Intimate Is It? | Genes (Basel) | 2023 | 36833239 | PubTator, text mining | PubMed |
| Sensitive Detection of Cell-Free Tumour DNA Using Optimised Targeted Sequencing Can Predict Prognosis in Gastro-Oesophageal Cancer. | Cancers (Basel) | 2023 | 36831507 | PubTator, text mining | PubMed |
| A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment Opportunities. | Cancers (Basel) | 2023 | 36831448 | PubTator, text mining | PubMed |
| Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape. | Cancers (Basel) | 2023 | 36831367 | PubTator, text mining | PubMed |
| Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response. | Cells | 2023 | 36831254 | PubTator, text mining | PubMed |
| The Role of HECT E3 Ubiquitin Ligases in Colorectal Cancer. | Biomedicines | 2023 | 36831013 | PubTator, text mining | PubMed |
| Serrated polyps in patients with ulcerative colitis: Unique clinicopathological and biological characteristics. | PLoS One | 2023 | 36827302 | PubTator, text mining | PubMed |
| The tumor biological significance of RNF43 and LRP1B in gastric cancer is complex and context-dependent. | Sci Rep | 2023 | 36823311 | PubTator, text mining | PubMed |
| CtDNA's prognostic value in patients with early-stage colorectal cancer after surgery: A meta-analysis and systematic review. | Medicine (Baltimore) | 2023 | 36820557 | PubTator, text mining | PubMed |
| Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer. | Front Oncol | 2023 | 36816981 | PubTator, text mining | PubMed |
| Genetic manipulation and targeted protein degradation in mammalian systems: practical considerations, tips and tricks for discovery research. | FEBS Open Bio | 2023 | 36815235 | PubTator, text mining | PubMed |
| RSPO3 Furin domain-conjugated liposomes for selective drug delivery to LGR5-high cells. | J Control Release | 2023 | 36813038 | PubTator, text mining | PubMed |
| Targeting the aryl hydrocarbon receptor by gut phenolic metabolites: A strategy towards gut inflammation. | Redox Biol | 2023 | 36812782 | PubTator, text mining | PubMed |
| Molecular Landscape and Association With Crohn Disease of Poorly Cohesive Carcinomas of the Nonampullary Small Bowel. | Am J Clin Pathol | 2023 | 36812376 | PubTator, text mining | PubMed |
| A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer. | Oncologist | 2023 | 36811382 | PubTator, text mining | PubMed |
| Pan-cancer clinical impact of latent drivers from double mutations. | Commun Biol | 2023 | 36808143 | PubTator, text mining | PubMed |
| Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors. | Neoplasia | 2023 | 36804751 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=22